Title : Follow-up of high-risk newborn infants

High-risk newborns—such as preterm infants, those with very low birth weight, and those requiring intensive neonatal care—are at increased risk for various health complications. Advances in neonatal medicine have improved survival, but these infants remain vulnerable to conditions affecting growth, neurodevelopment, and sensory functions. Prevention, treatment, and follow-up in outpatient settings of the achieved clinical improvement of these patients are required. 

Key aspects of follow-up include early detection and intervention for bronchopulmonary dysplasia, anemia, rickets, feeding and growth delays, and central nervous system injuries. Sensory impairments such as retinopathy of prematurity and hearing loss require systematic screening and specialist care.

Neurodevelopmental monitoring is essential and should be performed regularly using standardized tools such as the DDST-II, ASQ, and Bayley Scales. Cognitive, motor and behavioural development should be assessed from birth to school age at regular intervals according to the child's development, with early rehabilitation and specialised educational support provided when necessary. The main aim is to prepare the child for learning in a regular environment with their peers.

The follow-up strategy also includes individualized immunization planning, based on gestational age and clinical condition. A structured follow-up plan involving a multidisciplinary team—pediatricians, ophthalmologists, neurologists, and other specialists—is essential for optimal outcomes. Good collaboration between all these medical specialists is a prerequisite for better long-term results.

In conclusion, effective follow-up of high-risk newborns is crucial to minimize long-term morbidity and disability. It requires coordinated efforts, the establishment of clear protocols, and the active involvement of family and caregivers to support healthy development and quality of life.

Dr. Tatyana Itova, MD, PhD, is a pediatrician and neonatologist with extensive clinical experience in neonatal intensive care and the follow-up of preterm and high-risk infants. Her professional interests include neonatal intensive care, long-term neurodevelopmental follow-up, early intervention, and child health. She actively participates in national programs promoting early childhood development and developmental support. Dr. Itova is the Head of the Department of Neonatology at Medika University Hospital in Ruse, Bulgaria, and a lecturer at the University of Ruse “Angel Kanchev.”